陈宝安的代表奖项、课题、文章及专著

　 1. 2007年“白血病的耐药逆转研究”江苏省科技进步二等奖

2.2006年“消化道恶性肿瘤患者外周血微转移检测及微转移基因芯片研制及其应用”江苏省科学技术进步奖三等奖

3. 2006年“中西药结合增加血液系统肿瘤化疗敏感性的基础与临床研究”中国中西医结合学会科技奖三等奖

4.2009 年“多种方法逆转白血病多药耐药的研究及应用”获教育部科技进步二等奖。

5. 2011 年“基于纳米生物技术的肿瘤耐药识别与逆转的研究”获教育部科技进步二等奖。 1.王雪梅，张仁云，吕刚，吴春惠，李景源，高峰，程坚，陈宝安，付德刚，李小毛，

关之群. 治疗白血病的靶向磁性纳米药物及制备方法. 专利号：ZL 2005 1 0040657.1。

2.王雪梅，吴春惠，宋敏，李景源，张仁云，吴德洪，燕红，顾忠泽，陈宝安. 有机金

属碳硼烷靶向纳米制剂的制备方法及制成的靶向制剂. 专利号： ZL 2006 1 0096423.3。 1. 国家自然科学基金面上项目：汉防已甲素和角罗西芬逆转白血病细胞多药耐药的机理研究（编号：39970832，研究年限：2000.11－2002.12）已结题

2. 南京市重大课题：非清髓造血干细胞移植治疗白血病（编号：YQ0008，研究年限：2001－2004）已结题

3. 江苏省卫生厅科技发展基金：生物疗法在慢粒ASCT体外净化作用（编号：H200344，研究年限：2003－2005）已结题

4. 东南大学中大医院重大课题：非清髓造血干细胞移植治疗血液病（编号：2003YJ02，研究年限：2003－2005）已结题

5. 高等学校博士学科点专项科研基金：***聚合汉防己甲素和化疗药物的磁性纳米四氧化三铁颗粒在逆转恶性血液病多药耐药中的机理研究（编号：20070286042，研究年限：2008－2010）已结题

6. 国家自然基金面上项目：***聚合汉防己甲素和化疗药物的磁性纳米四氧化三铁颗粒在逆转恶性血液病多药耐药中的机理研究（编号：30740062，研究年限：2008－2009）已结题7. 国家自然基金面上项目：磁性纳米四氧化三铁颗粒***聚合柔红霉素和5－溴汉防己甲素逆转恶性血液病多药耐药的机理研究（编号：30872970，研究年限：2009－2011）已结题8. 国家高技术研究发展计划（863计划）子课题：急性白血病的治疗（研究年限：2009－2011）已结题

9. 国家高技术研究发展计划（863计划）子课题：超灵敏纳米多孔生物传感器件的研究与开发（编号：32007AA022007，研究年限：2009－2011）已结题

10. 国家重点基础研究发展计划（973计划）子课题：基于仿生分子识别的传感与成像方法研究及其系统设计（编号：2010CB732404，研究年限：2009-2015）在研

11. 国家科技支撑计划课题（十一五）子课题：骨髓增生异常综合征的规范化诊断与治疗策略研究（编号：2008BAI61B02，研究年限：2008－2010）已结题

12. 国家自然基金面上项目：化疗药和中药与转铁蛋白纳米载体的设计及逆转白血病耐药的机制研究（编号：81170492，研究年限：2012－2015）在研

13. 国家高技术研究发展计划（863计划）子课题：针对生物标志物检测的低成本检测系统的研制（编号：2012AA022703，研究年限：2012－2016）在研

14. 国家自然基金面上项目：血小板靶向载药系统的研制及其抗白血病效应的研究（编号：81370673，研究年限：2014－2017）在研

15. 江苏省科技厅医学重点项目：江苏省复发和难治性白血病的规范化治疗（编号：BL2014078，研究年限：2014－2017）在研 1.CaiX, Cai X, Wang C, Chen BA*, Hua W, Shen Fet al. Antitumor efficacy of DMSA modified Fe3O4 magneticnanoparticles combined with arsenic trioxide and adriamycin in Raji cells. J Biomed Nanotech2014; 10(2): 251-261.

2.ChangH, Wang X, Shiu KK, Zhu Y, Wang J, Li Q, Chen BA*et al. Layer-by-layer assembly of graphene, Au andpoly(toluidine blue O) films sensor for evaluation of oxidative stress of tumorcells elicited by hydrogen peroxide. Biosensors& Bioelectronics 2013; 41: 789-794.

3.ChengJ, Cheng L, Chen BA*, Xia G, Gao C, Song Het al. Effect of magnetic nanoparticles of Fe3O4 and wogonin onthe reversal of multidrug resistance in K562/A02 cell line. Int J Nanomedicine2012; 7: 2843-2852.

4.FangL, Chen BA,Liu S, Wang R, Hu S, Xia G, Chen BA*et al.Synergistic effect of a combination of nanoparticulate Fe3O4 and gambogic acidon phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells. Int JNanomedicine2012; 7: 4109-4118.

5.JiangN, Zhu X, Zhang H, Wang X, Zhou X, Gu J, Chen BA* et al. The relationship between methylenetetrahydrofolatereductase polymorphism and hematological malignancy. Clin Lab2014; 60(5): 767-774.

6.JinN, Malcherek G, Mani J, Zurleit R, Schmitt A, Chen BAet al. Suppression of cytomegalovirus-specific CD8(+)T cells by everolimus. Leuk Lymphoma 2014; 55(5): 1144-1150.

7.LiK, Chen BA*,Xu L, Feng J, Xia G, Cheng Jet al.Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4nanoparticles in A549/DDP lung cancer cells in vitro and in vivo. Int J Nanomedicine 2013; 8: 1867-1877.

8.LiangG, Li J, Sun B, Li S, Lu L, Wang Y, Chen BA*et al. Deep sequencing reveals complex mechanisms ofmicroRNA deregulation in colorectal cancer. IntJ Oncology 2014; 45(2): 603-610.

9.LuX, Zhu A, Cai X, Jia Z, Han W, Ma L, Chen BA*et al. Role of NKG2D in cytokine-induced killer cellsagainst multiple myeloma cells. CancerBio Therapy 2012; 13(8): 623-629.

10.MouY, Hou Y, Chen BA*, Hua Z, Zhang Y, Xie Het al. In vivo migration of dendritic cells labeled with syntheticsuperparamagnetic iron oxide. Int J Nanomedicine 2011; 6: 2633-2640.

11.RenY, Zhang H,Chen BA*, Cheng J, Cai X, Liu Ret al. Multifunctional magnetic Fe3O4 nanoparticles combined withchemotherapy and hyperthermia to overcome multidrug resistance. Int J Nanomedicine2012; 7: 2261-2269.

12.SongG, Gu L, Li J, Tang Z, Liu H, Chen BA* et al. Serum microRNAexpression profiling predict response to R-CHOP treatment in diffuse large Bcell lymphoma patients. Ann Hematol 2014.e-pub ahead of print 2014/05/27

13.WangC, Cai X, Chen BA*, He Z, Chen Z, Cen Jet al. Up-regulation of tissue inhibitor of metalloproteinase-2promotes SHI-1 cell invasion in nude mice. Leuk Lymphoma 2013; 54(12): 2707-2711.

14.WangC, Zhang H, Chen Y, Shi F, Chen BA*. Gambogic acid-loaded magnetic Fe(3)O(4)nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migrationby inactivating transcription factor ETS1. Int J Nanomedicine2012; 7: 781-787.

15.Wang F, Zhang W, Guo L, Bao W,Jin N, Liu R, Chen BA*et al. Gambogic acid suppresses hypoxia-inducedhypoxia-inducible factor-1alpha /vascular endothelial growth factor expressionvia inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein ofrapamycin pathway in multiple myeloma cells. Cancer Sci2014. e-pub ahead of print 2014/06/04.

16.WangL, Zhang H, Chen BA*, Xia G, Wang S, Cheng Jet al. Effect of magnetic nanoparticleson apoptosis and cell cycle induced by wogonin in Raji cells. Int J Nanomedicine2012; 7: 789-798.

17.WangX, Wang X, Gao S, Zheng Y, Tang M, ChenBA*. A solid-state electrochemiluminescencesensing platform for detection of catechol based on novel luminescent compositenanofibers. Talanta 2013; 107: 127-132.

18.WenJ, Jiang S, Chen Z, Zhao W, Yi Y, Yang R, Chen BA* et al. Apoptosis selectively induced in BEL-7402 cells byfolic acid-modified magnetic nanoparticles combined with 100 Hz magnetic field.Int J Nanomedicine2014; 9: 2043-2050.

19.XuP,Chen BA*,Feng J, Cheng L, Xia G, Li Yet al.Polymorphisms in XPC provide prognostic information in acute myeloid leukemia. IntJ Hematology 2012; 96(4): 450-460.

20.XuP, Li J, Chen BA*, Wang X, Cai X, Jiang Het al. The real-time neurotoxicityanalysis of Fe3O4 nanoparticles combined with daunorubicin for rat brain invivo. JBiomed Nanotechnology 2012; 8(3): 417-423.

21.XuP, Li J, Shi L, Selke M, Chen BA*, Wang X. Synergetic effect of functionalcadmium-tellurium quantum dots conjugated with gambogic acid for HepG2cell-labeling and proliferation inhibition. Int J Nanomedicine2013; 8: 3729-3736.

22.XuY, Wang Y, Li XM, Huang Q, Chen W, Liu R, Chen BA*et al. Study on the release of fenofibrate nanosuspension invitro and its correlation with in situ intestinal and in vivo absorptionkinetics in rats. Drug Dev Indus Pharmacy2014; 40(7): 972-979.

23.YangZ, Chen BA*,Pei X, Shangguan F. Multiplex analysis of tumor multidrug-resistance genesexpression with photonic suspension array. TheAnalyst 2012; 137(14): 3343-3348.

24.ZhangH, Wang C, Chen BA*, Wang X. Daunorubicin-TiO2 nanocompositesas a smart pH-responsive drug delivery system. Int J Nanomedicine2012; 7: 235-242.

25.ZhongY, Wu J, Chen BA*, Ma R, Cao H, Wang Zet al. Investigation and analysis of single nucleotidepolymorphisms in Janus kinase/signal transducer and activator of transcriptiongenes with leukemia. Leuk Lymphoma 2012; 53(6): 1216-1221.

26. Zhang HJ, Chen BA*,Jiang H, Wang CL, Wang HP, Wang XM. A strategy for ZnO nanorod mediatedmulti-mode cancer treatment. Biomaterials. 2011; 32(7):1906-14.

27. Chen BA*, Wu WW, WangXM. Magnetic Iron Oxide Nanoparticles for Tumor-targeted Therapy. Curr CancerDrug Targets 2011; 11(2):184-9.

28. Zhang HJ, Jiang H, Sun FF, Wang HP, Zhao J, Chen BA*, Wang XM. Rapid diagnosis of multidrug resistance in cancerby electrochemical sensor based on carbon nanotubes-drug supramolecularnanocomposites. Biosens Bioelectron. 2011; 26(7):3361-6.

29. Song M, Zhang RR, Dai YY, Gao F, Chi H, Lv G, Chen BA,* Wang XM. The in vitro inhibitionof multidrug resistance by combined nanoparticulate titanium dioxide and UV irradition.Biomaterials. 2006; 27(23):4230-8.

30. Chen BA*, Yin L, ChengJ, Ding JH, Gao C, Sun YY, Zhao G, Wang J, Bao W, Xia GH, Gao F, Wang XM.Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1 -propanol andtetrandrine on the reversion of multidrug resistance in K562/A02 cells.Hematology. 2011; 16(1):24-30.

31. Wu WW, Chen BA*, ChengJ, Wang J, Xu WL, Liu LJ, Xia GH, Wei H, Wang XM, Yang M, Yang L, Zhang Y, XuC, Li J. Biocompatibility of Fe3O4/DNR magnetic nanoparticles inthe treatmentof hematologic malignancies. Int J Nanomedicine. 2010; 5:1079-84.

32. Wang J, Chen Y,Chen BA*,Ding JH, Xia GH, Gao C, Cheng J, Jin N, Zhou Y, Li XM, Tang M, Wang XM.Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticlesin mice. Int J Nanomedicine. 2010; 5:861-6.

33. Chen BA*, Mao P, ChengJ, Gao F, Xia GH, Xu WL, Shen HL, Ding JH, Gao C, Sun Q, Chen W, Chen N, LiuLJ, Li XM, Wang XM. Reversal of multidrug resistance by magnetic Fe3O4nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector inleukemia cells. Int J Nanomedicine. 2010; 5:437-4.

34. Chen BA*, Jin N, WangJ, Ding JH, Gao C, Cheng J, Xia GH, Gao F, Zhou Y, Chen Y, Zhou G, Li XM, ZhangY, Tang M, Wang XM. The effect of magnetic nanoparticles of Fe(3)O(4) on immunefunction in normal ICR mice. Int J Nanomedicine. 2010; 5:593-9.

35. Zhang HJ, Jiang H, Wang XM,Chen BA*. Reversion of multidrugresistance in tumor by biocompatible nanomaterials. Mini Rev Med Chem. 2010;10(8):737-45.

36. Zhong YJ, Chen BA*,Feng JF, Cheng L, Li Y, Qian J, Ding JH, Gao F, Xia GH, Chen N, Lu Z. Theassociations of Janus kinase-2 (JAK2) A830G polymorphism and the treatment outcomesin patients with acute myeloid leukemia. Leuk Lymphoma. 2010; 51(6):1115-20.

37. Zhu XL, Zhang HJ, Lin Y, Chen P, Min J, Wang Z, Xiao W, Chen BA*. Mechanisms of gambogicacid-induced apoptosis in non-small cell lung cancer cells in relation to transferrinreceptors. J Chemother. 2009; 21(6):666-72.

38. Pei XP, Chen BA*, LiL, Gao F, Jiang Z. Multiplex tumor marker detection with new chemiluminescentimmunoassay based on silica colloidal crystal beads. Analyst. 2010; 135(1):177-81.

39. Chen BA*, Liang YQ, WuWW, Cheng J, Xia GH, Gao F, Ding JH, Gao C, Shao Z, Li G, Chen W, Xu WL, SunXC, Liu LJ, Li XM, Wang XM. Synergistic effect of magnetic nanoparticles ofFe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells. Int J Nanomedicine.2009; 4:251-9.

40. Cheng J, Wu WW, Chen BA*,Gao F, Xu WL, Gao C, Ding JH, Sun YY, Song HH, Bao W, Sun XC, Xu C, Chen W,Chen N, Liu LJ, Xia GH, Li XM, Wang XM. Effect of magnetic nanoparticles ofFe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02leukemic cells. Int J Nanomedicine. 2009; 4:209-16.

41. Pei XP, Zhao Y, Zhao X, Xu H, Chen BA*, Gu ZZ. Multiplex chemiluminescent immunoassay based onsilica colloidal crystal beads. J N N. 2009; 9(11):6320-5.

42. Sun N, Sun XC, Chen BA*,Cheng H, Feng JF, Cheng L, Lu ZH. MRP2 and GSTP1 polymorphisms and chemotherapyresponse in advanced non-small cell lung cancer. Cancer Chemoth Pharm. 2010;65(3):437-46.

43. Li Y, Deng Z, Xuan H, Zhu J, Ding B, Liu X, Chen BA*. Prolonged chronic phase in chronic myelogenous leukemiaafter homoharringtonine therapy. Chin Med J (Engl). 2009;122(12):1413-7.

44. Jiang Z, Chen BA*, XiaGH, Wu Q, Zhang Y, Hong T, Zhang W, Cheng J, Gao F, Liu LJ, Li XM, Wang XM. Thereversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin onSKOV3/DDP ovarian carcinoma cells. Int J Nanomedicine. 2009; 4:107-14.

45. Chen BA*, Cheng J, WuYN, Gao F, Xu WL, Shen HL, Ding JH, Gao C, Sun Q, Sun XC, Cheng H, Li G, ChenW, Chen N, Liu LJ, Li XM, Wang XM. Reversal of multidrug resistance by magneticFe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine inxenograft nude-mice. Int J Nanomedicine. 2009; 4:73-8.

46. Chen BA*, Cheng J,Shen MF, Gao F, Xu WL, Shen HL, Ding JH, Gao C, Sun Q, Sun XC, Cheng H, Li G,Chen W, Chen N, Liu LJ, Li XM, Wang XM. Magnetic nanoparticle of Fe3O4 and5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin inleukemia cells. Int J Nanomedicine. 2009; 4:65-71.

47. Chen BA*, Dai YY, WangXM, Zhang R, Xu WL, Shen HL, Gao F, Sun Q, Deng X, Ding JH, Gao C, Sun Y, ChengJ, Wang J, Zhao G, Chen N. Synergistic effect of the combination of nanoparticulateFe3O4 and Au with daunomycin on K562/A02 cells. Int J Nanomedicine. 2008;3(3):343-50.

48. Chen BA*, Sun Q, WangXM, Gao F, Dai YY, Yin Y, Ding JH, Gao C, Cheng J, Li JY, Sun XC, Chen N, XuWL, Shen HL, Liu D. Reversal in multidrug resistance by magnetic nanoparticleof Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells. IntJ Nanomedicine. 2008; 3(2):277-86.